Discordant immune response among treatment experienced patients infected with HIV-1: Crosstalk between MiRNAs expression and CD4+ T cells count

Autor: Poorghobadi, Shima, Agharezaei, Mina, Ghanbari, Maryam, Bahramali, Golnaz, Abbasian, Ladan, Sajadipour, Mansour, Baesi, Kazem

Publikováno v: In International Immunopharmacology January 2023 114

What explains gender inequality in HIV infection among high-risk people? A Blinder-Oaxaca decomposition

Autor: Sajadipour, Mansour, Rezaei, Satar, Irandoost, Seyed Fahim, Ghaumzadeh, Mohammadreza, Salmani nadushan, Mohamadreza, Gholami, Mohammad, Salimi, Yahya, Jorjoran Shushtari, Zahra

Publikováno v: Archives of Public Health, Vol 80, Iss 1, Pp 1-9 (2022)
Archives of Public Health

Background Despite clear evidence on role of gender in vulnerability and exposure to HIV infection, information on gender-related inequalities in HIV and related factors are rarely documented. The aim of this study was to measure gender inequality in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::010f5653cf62ae6cee6a1b7fc97d47bc
https://doi.org/10.1186/s13690-021-00758-2

The Relationship Between HIV Antibody Titer, HIV Viral Load, HIV p24 Antigen, and CD4 T-cell Count Among Iranian HIV-positive Patients.

Autor: Moradbeigi M; Department of Clinical Biochemistry, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., SeyedAlinaghi S; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran., Sajadipour M; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran., Dadras O; Department of Global Health and Socioepidemiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Shojaei E; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran., Ahmadi P; Chemistry Faculty, Khajenasir Toosi University of Technology, Tehran, Iran., Bayanolhagh S; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran., Baesi K; Hepatitis and AIDS Department, Pasteur Institute of Iran, Tehran, Iran., Rasoolinejad M; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.

Publikováno v: Infectious disorders drug targets [Infect Disord Drug Targets] 2020; Vol. 20 (5), pp. 752-757.